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CLINICAL PRACTICE
CHRONIC PRIMARY HEADACHE -
REDUCING THE RISK OF
TREATMENT
Ivan Cohen
Headaches have plagued mankind for more than 5 000 years'
and yet they are still one of the most common reasons for
medical consultation. Approximately 70 - 75% of men and more
than 80% of women suffer from headaches each year.2-4 The
uprin Pain Report,' produced by Bristol Meyers in 1985,
indicated that 550 million work days were lost in 1 year by
Americans because of pain, which resulted in 55 billion dollars
of lost revenue. In the uprin Pain Report, 73% of the subjects
reported that they suffered from headaches.
CLASSIFICATION
To facilitate management and research, headaches have been
classified according to clinical criteria. Commonly used
headache classifications are the classification by the Ad Hoc
Committee on Classification of Headache: the classification
developed by Diamond: and the classification by the Headache
Classification Committee" of the International Headache
Society. Diamond's frequently used classification categorises
headaches into vascular (including the migraine family),
muscle contraction (tension) and traction/inflammatory
(organic). Evidence has accumulated to suggest that there are
many similarities between tension and migraine headaches,
and there is therefore growing support for the existence of a
continuum between the twO.9-'2
The majority of chronic headaches are vascular and tension
in type and idiopathic in origin. Moreover, acute headaches are
usually also idiopathic; it has been estimated that only 0.004%
of acute headaches are a symptom of serious underlying
disease. 13 It has been suggested that because medical training
traditionally emphasises headache as a symptom of underlying
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pathology rather than as a primary disorder, medical
practitioners may feel that their responsibility to the patient has
been discharged when pathology has been excluded. I"
Furthermore, many practitioners may perceive that chronic
headaches are unrewarding disorders to treat.'"
On the other hand, surveys among headache sufferers
indicate that they are severely dissatisfied with medical care. In
one study, nearly three-quarters of headache patients reported
dissatisfaction with medical treatment, citing as sources of their
dissatisfaction medical practitioner bias, lack of compassion
and understanding, and inadequate explanation. I' Only 11% of
158 migraine sufferers participating in a clinical trial described
their usual headache therapy as being very good, and only 5%
believed that they received sufficient doses of medication to
.treat a migraine attack. l •
MANAGEMENT
Headache is typically managed with symptomatic
medications,l7 the potential risks of which include rebounG
headache, drug-induced chronic headache, reduced
effectiveness of prophylactic headache medications, symptoms
associated with cessation of headache medications, and other
side--effects.' Chronic headache may be precipitated by
frequent use of paracetamol, aspirin, opioids, non-steroidal
anti-inflammatory drugs, muscle relaxants and ergotamine
tartrate. I9-2" Moreover, according to the drug abuse criteria of the
International Headache Society,25 a considerable proportion of
headache patients abuses drugs.
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Education and preventative therapy, on the other hand, may
reduce chronic use of symptomatic headache medications and
may therefore improve prognosis. IS For reasons given above, it
is important that headache prevention therapy has a low risk of
side-effects and chemical dependence. One form of headache
prevention therapy with no risk of systemic side-effects or
chemical dependence is the use of intra-oral occlusal splints
(10S), also used to treat functional disorders of the masticatory
system. These disorders of the masticatory system are known
by a variety of names, including temporomandibular disorder
(TMD), mandibular dysfunction, craniomandibular disorder,
myofacial pain dysfunction and Costen's syndrome.
INTRA-ORAL SPLINTS
Several epidemiological studies have shown that an association
exists between headache and functional disorders of the
masticatory system.26-29The above association has been recorded
in clinical studies of TMD,">-32 and treatment of TMD has also
been shown to reduce the incidence of headache.33-37
To assess the value of 10S in the prevention of headaches,
studies should be controlled with placebo treatments, blinding
and randomisation. However, Moses38.J9 has argued that
investigation of pain caused by TMD constitutes poor research
methodology because TMD is a generic diagnosis for a large
number of different disorders with a common symptomatology
and there are too many other confounding factors, such as
referred pain, poorly localised pain and inaccuracy of TMD
pain reports.38.J9 Moses38.J9 contends that pain in TMD is
therefore 'untestable, unmeasurable and unreliable', and must
be considered unscientific as a criterion for research.
In a study conducted on the therapeutic efficacy of intra-oral
splints using a parallel, randomised, controlled and blind
design, it was found that significant reduction of pain was
achieved to a similar degree, irrespective of whether the groups
used a subpalatal or a full occlusal splint. Tlffie periods varied
between groups from 30 minutes per week to 24 hours per
day.'" The authors concluded that the effect of treatment was
nonspecific and not related to the type or duration of 105
therapy. However, although significant reductions of pain were
found in all the groups,'" the fact that there were no inter-group
differences in pain reduction may have been a result of the
practical difficulties of using pain as a determinant of treatment
outcome in TMD research.38.J9
THE TMD DILEMMA
A further difficulty with placebo-controlled research of TMD
using 105 relates to the mode of administration of the placebo,
which can influence the placebo's effects." Placebo-controlled
research on the therapeutic effects of 105 therefore necessitates
an intra-oral placebo. However, an intra-oral placebo can
modify the function of the masticatory system by modifying
cognitive awareness and masticatory muscle function,
consequences which cannot be ascribed to pure placebo
effects.-l2
The mechanisms of the association between TMD and
headaches have not yet been clarified. Similarly, the
mechanisms whereby 10S may reduce headaches also require
elucidation. However, there is evidence of a reduction of
chronic headache in association with 10S therapY,33-37 even in
patients who failed to respond to standard pharmacotherapy
prescribed in a neurology clinic." Moreover, the response of
headache symptoms to 10S therapy is not associated with the
presence or absence of other symptoms and signs of TMD."
The presence or absence of other clinical features of TMD is
therefore not a reliable prognostic indicator of the likelihood of
success of 10S therapy in the treatment of headache.
The percentage of patients with reduction of headache using
IOS therapy has been reported to be 33%" (tension headache),
82%" (combined tension-migraine headache) and 50%,37 68%35
and 91 %36 (type not specified). Patients with migraine and
tension vascular headache have been reported to benefit from
IOS therapy more than patients with pure chronic tension
headache."
Despite the fact that the mechanisms whereby 105 may
reduce headaches have not been clarified, the potential benefits
of 105 therapy in the management of headaches outweigh the
disadvantages: there are no contraindications (other than oral
disease or allergy to the acrylic material, both of which are
rare) and no systemic side-effects, the ongoing treatment cost is
low, treatment is non-invasive and reversible, and chemical
dependence does not occur. Moreover, when patients with
chronic primary headache do not experience relief on 105
therapy, such failure does not contraindicate other
management. 105 therapy should therefore be provided to
patients with chronic primary headache by a suitably qualified
dental surgeon. The dental surgeon will adapt the design of the
105 to suit each patient's clinical presentation. In patients
complaining of headache, 105 should not be used until medical
examination has excluded the possibility of an organic
disorder.
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PERSONAL VIEW
ARE OUR SPORTSMEN AND
WOMEN GETTING A FAIR
MEDICAL DEAL?
P Firer, M Ferguson
South Africa is blessed with a large and top-rate sporting
population and with top-rate doctors and scientists interested
in all aspects of management of sports participation.
Yet somehow our players are being short-changed.
Do top-rated international cricketers have to be trundled
around England for numerous assessments and investigations
by people not really known to the team management, only to
be sent home for diagnoses and a management plan? This on
two separate tours!
Does an international soccer goalkeeper have to undergo
outdated investigations, followed by an unnecessary operation
in a foreign country by a surgeon totally unknown to the team
management, the player, or even the orthopaedic community
in South Africa, then to be told that he needs another operation
to correct his problem?
Does an international hockey goalkeeper have to have an
injury for 6 weeks before a diagnosis is made and it is too late
for adequate treatment to enable him to participate pain-free in
an international event?
Do our sporting teams have to tour without the most
experienced experts to handle their problems?
There is also a growing misconception in South Africa that
we can produce 'sports medicine specialists'. There is no such
individual, and it is impossible for one person to attain the
necessary knowledge and experience.
Let us consider the fields of sports medicine and break them
up into 'pre-participation' and 'in-competition' areas as far as
the sportsman is concerned.
Ponky Firer and Mark Ferguson specialised in orthopaedic
surgery at Wits and are in separate private practices in
Johannesburg. They have a common interest in orthopaedic sports
trauma, Or Firer concentrating on the knee and Dr Ferguson on
the shoulder. Both are committed to the principle that every
sportsman should have the right to be treated by specialists
specifically trained, experienced and interested in sports injuries,
and this article was prompted by their frustration at the poor
handling of some ofour international athletes.
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